Skip to main content
FibroBiologics, Inc. logo

FibroBiologics, Inc. — Investor Relations & Filings

Ticker · FBLG ISIN · US31573L1052 LEI · 5493000KQEGHXVWRMZ92 US Manufacturing
Filings indexed 185 across all filing types
Latest filing 2025-11-19 Regulatory Filings
Country US United States of America
Listing US FBLG

About FibroBiologics, Inc.

https://fibrobiologics.com/

FibroBiologics, Inc. is a clinical-stage biotechnology company focused on developing fibroblast cell-based therapies for chronic diseases. The company utilizes the regenerative and immune-modulating properties of fibroblasts, the primary cell type in connective tissue, to create treatments for conditions where there is a significant unmet medical need. Its development pipeline targets multiple sclerosis, degenerative disc disease, and wound healing. FibroBiologics is also advancing a bone marrow organoid platform for potential applications in cancer and immune-related therapies. The company's research and development are supported by an intellectual property portfolio of over 160 issued patents.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-11-19 English
10-Q
Interim / Quarterly Report 9M 2025
2025-10-31 English
8-K
Regulatory Filings
2025-08-08 English
10-Q
Interim / Quarterly Report Q2 2025
2025-07-31 English
8-K/A
Regulatory Filings
2025-07-18 English
8-K
Regulatory Filings
2025-07-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.